Teladoc Health, Inc. reported second-quarter 2026 results with revenue of $606.93M, a 4% decline from $631.9M a year earlier, and a net loss of ($38.91M) compared with a ($32.66M) loss in the prior-year quarter; diluted loss per share was ($0.21) versus ($0.19) a year ago.
Financial Highlights
| MetricCurrent quarterPrior year quarterYoY change | Revenue¹$606.93M$631.9M(4%) | Net income²($38.91M)($32.66M)(19.1%) | Diluted EPS³($0.21)($0.19)(10.5%) |
¹ Reported as “Revenue”. ² Reported as “Net loss”. ³ Reported as “loss per share, basic and diluted”.
Business Highlights
- Revenue decline driven by weaker BetterHelp performance, partly offset by growth in Integrated Care.
- BetterHelp is experiencing a rapid channel shift from cash-pay to insurance, reducing cash revenue and requiring capacity build-up to serve insured members.
- Marketing spend was reduced (about 14% in the quarter and 12% year-to-date) to better align demand with insurance-provider capacity.
- Provider licensing, credentialing and payer enrollments constrained the pace of insurance conversions and visit volume.
- Integrated Care membership remained stable with rising chronic care enrollments (up 14% YTD) and improving margins.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.